{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T21:56:17Z","timestamp":1790546177290,"version":"4.1.0"},"reference-count":76,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,14]],"date-time":"2024-06-14T00:00:00Z","timestamp":1718323200000},"content-version":"vor","delay-in-days":13,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81673842"],"award-info":[{"award-number":["81673842"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2019A1515011745"],"award-info":[{"award-number":["2019A1515011745"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.heliyon.2024.e33102","type":"journal-article","created":{"date-parts":[[2024,6,17]],"date-time":"2024-06-17T19:57:54Z","timestamp":1718654274000},"page":"e33102","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Network pharmacology and experimental validation to explore the mechanism of Changji'an formula against irritable bowel syndrome with predominant diarrhea"],"prefix":"10.1016","volume":"10","author":[{"given":"Wei","family":"Ke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinjun","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongbin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyu","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huibiao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongfu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingxiu","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuncong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongmei","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-3367-2692","authenticated-orcid":false,"given":"Kaijun","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.heliyon.2024.e33102_bib1","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1001\/jama.2015.0954","article-title":"Irritable bowel syndrome: a clinical review","volume":"313","author":"Chey","year":"2015","journal-title":"JAMA"},{"issue":"26","key":"10.1016\/j.heliyon.2024.e33102_bib2","doi-asserted-by":"crossref","first-page":"8103","DOI":"10.3748\/wjg.v21.i26.8103","article-title":"Patients with irritable bowel syndrome-diarrhea have lower disease-specific quality of life than irritable bowel syndrome-constipation","volume":"21","author":"Singh","year":"2015","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.heliyon.2024.e33102_bib3","article-title":"Bowel disorders","author":"Mearin","year":"2016","journal-title":"Gastroenterology"},{"issue":"26","key":"10.1016\/j.heliyon.2024.e33102_bib4","doi-asserted-by":"crossref","first-page":"2566","DOI":"10.1056\/NEJMra1607547","article-title":"Irritable bowel syndrome","volume":"376","author":"Ford","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.heliyon.2024.e33102_bib5","first-page":"5698","article-title":"Discussion and consideration on the essence of \u2018stagnation of liver qi and spleen deficiency\u2019 in diarrhea-predominant irritable bowel syndrome","volume":"35","author":"Chen","year":"2020","journal-title":"China J. Traditional Chin. Med. Pharmacy"},{"key":"10.1016\/j.heliyon.2024.e33102_bib6","article-title":"Treatment of 87 patients with irritable bowel syndrome by traditional Chinese medicine","volume":"42","author":"Chen","year":"1988","journal-title":"Liaoning J. Traditional Chin. Med."},{"key":"10.1016\/j.heliyon.2024.e33102_bib7","first-page":"52","article-title":"Treating 30 cases of diarrhea type irritable bowel syndrome with Tongxie Yaofang plus four noble drugs decoction","volume":"25","author":"Gong","year":"2011","journal-title":"J. Pract. Traditional Chin. Internal Med."},{"key":"10.1016\/j.heliyon.2024.e33102_bib8","first-page":"3669","article-title":"Effect of Tongxie Yaofang combined with Sijunzi decoction on immune function of patients with IBS-D","volume":"38","author":"Zhuo","year":"2017","journal-title":"Guangdong Med. J."},{"key":"10.1016\/j.heliyon.2024.e33102_bib9","first-page":"157","article-title":"Clinical efficacy of Tongxiyaofang combined with Sijunzi Decoction in the treatment of irritable bowel syndrome and its influence on immune function","volume":"12","author":"Liu","year":"2019","journal-title":"Chin J of Clinical Rational Drug Use"},{"key":"10.1016\/j.heliyon.2024.e33102_bib10","first-page":"30","article-title":"Treatment of 42 patients with IBS-D (spleen deficiency and liver depression syndrome) with Sijunzi decoction combined with Tongxie Yaofang","volume":"45","author":"Wen","year":"2014","journal-title":"Fujian J. TCM"},{"key":"10.1016\/j.heliyon.2024.e33102_bib11","first-page":"93","article-title":"Effect of Shugan Jianpi method (Changji'an Fomulation) on IBS-D immune function","volume":"22","author":"Chai","year":"2016","journal-title":"Chin. J. Exp. Tradit. Med. Formulae"},{"key":"10.1016\/j.heliyon.2024.e33102_bib12","first-page":"80","article-title":"Effect of Changji'an prescription on intestinal permeability of IBS-D rats","volume":"25","author":"Shi","year":"2019","journal-title":"Chin. J. Exp. Tradit. Med. Formulae"},{"issue":"11","key":"10.1016\/j.heliyon.2024.e33102_bib13","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/nchembio.118","article-title":"Network pharmacology: the next paradigm in drug discovery","volume":"4","author":"Hopkins","year":"2008","journal-title":"Nat. Chem. Biol."},{"issue":"7061","key":"10.1016\/j.heliyon.2024.e33102_bib14","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1038\/437942a","article-title":"Drug discovery: playing dirty","volume":"437","author":"Frantz","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.heliyon.2024.e33102_bib15","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.727608","article-title":"Network pharmacology and molecular docking analysis on molecular mechanism of Qingzi Zhitong decoction in the treatment of ulcerative colitis","volume":"13","author":"Shou","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.heliyon.2024.e33102_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2021.114119","article-title":"The mechanisms of action of WeiChang'An Pill (WCAP) treat diarrhoea-predominant irritable bowel syndrome (IBS-D) using network pharmacology approach and in vivo studies","volume":"275","author":"Chen","year":"2021","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.heliyon.2024.e33102_bib17","article-title":"Network pharmacology identifies the mechanisms of action of Tongxie Anchang decoction in the treatment of irritable bowel syndrome with diarrhea predominant","volume":"2020","author":"Tan","year":"2020","journal-title":"Evid. base Compl. Alternative Med. : ECAM."},{"key":"10.1016\/j.heliyon.2024.e33102_bib18","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.746923","article-title":"An integrated gut microbiota and network pharmacology study on Fuzi-Lizhong Pill for treating diarrhea-predominant irritable bowel syndrome","volume":"12","author":"Zhen","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.heliyon.2024.e33102_bib19","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.1027112","article-title":"Exploring the mechanism of Alisma orientale for the treatment of pregnancy induced hypertension and potential hepato-nephrotoxicity by using network pharmacology, network toxicology, molecular docking and molecular dynamics simulation","volume":"13","author":"Liao","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.heliyon.2024.e33102_bib20","article-title":"Integrating network pharmacology and experimental validation to investigate the effects and mechanism of Astragalus flavonoids against hepatic fibrosis","volume":"11","author":"An","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.heliyon.2024.e33102_bib21","first-page":"2302","article-title":"Simultaneous determination of ten constituents in lyophilized powder of Changji'an Prescription by UHPLC-MS\/MS","volume":"43","author":"Wu","year":"2021","journal-title":"Chin. Tradit. Pat. Med."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e33102_bib22","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1053\/j.gastro.2022.04.017","article-title":"AGA clinical practice guideline on the pharmacological management of irritable bowel syndrome with diarrhea","volume":"163","author":"Lembo","year":"2022","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.heliyon.2024.e33102_bib23","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2013.10.026","article-title":"Rifaximin alters intestinal bacteria and prevents stress-induced gut inflammation and visceral hyperalgesia in rats","volume":"146","author":"Xu","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.heliyon.2024.e33102_bib24","first-page":"853","article-title":"Determination of paeoniflorin, palmatine hydrochloride and berberine hydrochloride in Changji'an Preparation by HPLC","volume":"34","author":"Tang","year":"2012","journal-title":"Chin. Tradit. Pat. Med."},{"issue":"12","key":"10.1016\/j.heliyon.2024.e33102_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2022.e12312","article-title":"Paeoniflorin alleviates inflammatory response in IBS-D mouse model via downregulation of the NLRP3 inflammasome pathway with involvement of miR-29a","volume":"8","author":"Ke","year":"2022","journal-title":"Heliyon"},{"issue":"8","key":"10.1016\/j.heliyon.2024.e33102_bib26","doi-asserted-by":"crossref","first-page":"e187","DOI":"10.1038\/ctg.2016.44","article-title":"Rifaximin exerts beneficial effects independent of its ability to alter microbiota composition","volume":"7","author":"Kang","year":"2016","journal-title":"Clin. Transl. Gastroenterol."},{"issue":"7844","key":"10.1016\/j.heliyon.2024.e33102_bib27","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/s41586-020-03118-2","article-title":"Local immune response to food antigens drives meal-induced abdominal pain","volume":"590","author":"Aguilera-Lizarraga","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.heliyon.2024.e33102_bib28","doi-asserted-by":"crossref","first-page":"4671","DOI":"10.2147\/DDDT.S246619","article-title":"The effects of short-chain fatty acids on rat colonic hypermotility induced by water avoidance stress","volume":"14","author":"Yuan","year":"2020","journal-title":"Drug Des. Dev. Ther."},{"issue":"5","key":"10.1016\/j.heliyon.2024.e33102_bib29","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1053\/gast.2000.19576","article-title":"A new model of chronic visceral hypersensitivity in adult rats induced by colon irritation during postnatal development","volume":"119","author":"Al-Chaer","year":"2000","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.heliyon.2024.e33102_bib30","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1046\/j.1365-2249.1999.00878.x","article-title":"Interferon-gamma (IFN-gamma)- and tumour necrosis factor (TNF)-induced nitric oxide as toxic effector molecule in chronic dextran sulphate sodium (DSS)-induced colitis in mice","volume":"116","author":"Obermeier","year":"1999","journal-title":"Clin. Exp. Immunol."},{"issue":"10","key":"10.1016\/j.heliyon.2024.e33102_bib31","doi-asserted-by":"crossref","DOI":"10.3390\/cells10102593","article-title":"New insights into intestinal permeability in irritable bowel syndrome-like disorders: histological and ultrastructural findings of duodenal biopsies","volume":"10","author":"Miglietta","year":"2021","journal-title":"Cells"},{"issue":"4","key":"10.1016\/j.heliyon.2024.e33102_bib32","doi-asserted-by":"crossref","first-page":"558","DOI":"10.5056\/jnm16001","article-title":"The role of visceral hypersensitivity in irritable bowel syndrome: pharmacological targets and novel treatments","volume":"22","author":"Farzaei","year":"2016","journal-title":"J. Neurogastroenterology and Motility"},{"issue":"6","key":"10.1016\/j.heliyon.2024.e33102_bib33","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1016\/0016-5085(94)90809-5","article-title":"Evidence for the hypersensitivity of lumbar splanchnic afferents in irritable bowel syndrome","volume":"107","author":"Lembo","year":"1994","journal-title":"Gastroenterology"},{"key":"10.1016\/j.heliyon.2024.e33102_bib34","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.pharmthera.2018.02.011","article-title":"Inflammasome biology, molecular pathology and therapeutic implications","volume":"187","author":"Awad","year":"2018","journal-title":"Pharmacol. Therapeut."},{"key":"10.1016\/j.heliyon.2024.e33102_bib35","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.767456","article-title":"IL-1\u03b2 and the intestinal epithelial tight junction barrier","volume":"12","author":"Kaminsky","year":"2021","journal-title":"Front. Immunol."},{"issue":"11\u201312","key":"10.1016\/j.heliyon.2024.e33102_bib36","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1111\/apt.12080","article-title":"Review article: associations between immune activation, intestinal permeability and the irritable bowel syndrome","volume":"36","author":"Matricon","year":"2012","journal-title":"Aliment. Pharmacol. Ther."},{"issue":"11","key":"10.1016\/j.heliyon.2024.e33102_bib37","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines8110519","article-title":"Modulation of NLRP3 inflammasome attenuated inflammatory response associated to diarrhea-predominant irritable bowel syndrome","volume":"8","author":"Scuderi","year":"2020","journal-title":"Biomedicines"},{"issue":"2","key":"10.1016\/j.heliyon.2024.e33102_bib38","doi-asserted-by":"crossref","first-page":"787","DOI":"10.4049\/jimmunol.0901363","article-title":"Cutting edge: NF-kappaB activating pattern recognition and cytokine receptors license NLRP3 inflammasome activation by regulating NLRP3 expression","volume":"183","author":"Bauernfeind","year":"2009","journal-title":"J. Immunol. (Baltimore, Md"},{"issue":"18","key":"10.1016\/j.heliyon.2024.e33102_bib39","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1101\/gad.1228704","article-title":"Signaling to NF-kappaB","volume":"18","author":"Hayden","year":"2004","journal-title":"Gene Dev."},{"issue":"6","key":"10.1016\/j.heliyon.2024.e33102_bib40","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.cell.2010.01.040","article-title":"The inflammasomes","volume":"140","author":"Schroder","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.heliyon.2024.e33102_bib41","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.phymed.2017.03.001","article-title":"Atractylenolide I stimulates intestinal epithelial repair through polyamine-mediated Ca2+ signaling pathway","volume":"28","author":"Song","year":"2017","journal-title":"Phytomedicine : Int. J. Phytother. Phytopharmacology."},{"key":"10.1016\/j.heliyon.2024.e33102_bib42","doi-asserted-by":"crossref","DOI":"10.1177\/1756284821993586","article-title":"Intestinal barrier dysfunction in irritable bowel syndrome: a systematic review","volume":"14","author":"Hanning","year":"2021","journal-title":"Therapeutic Advances In Gastroenterology"},{"issue":"6","key":"10.1016\/j.heliyon.2024.e33102_bib43","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.jpain.2007.12.009","article-title":"The analgesic effect of paeoniflorin on neonatal maternal separation-induced visceral hyperalgesia in rats","volume":"9","author":"Zhang","year":"2008","journal-title":"J. Pain"},{"key":"10.1016\/j.heliyon.2024.e33102_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2021.107667","article-title":"Paeoniflorin protects against dextran sulfate sodium (DSS)-induced colitis in mice through inhibition of inflammation and eosinophil infiltration","volume":"97","author":"Li","year":"2021","journal-title":"Int. Immunopharm."},{"key":"10.1016\/j.heliyon.2024.e33102_bib45","article-title":"Astragaloside IV ameliorates 2,4,6-trinitrobenzene sulfonic acid (TNBS)-induced colitis implicating regulation of energy metabolism","volume":"7","author":"Jiang","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.heliyon.2024.e33102_bib46","doi-asserted-by":"crossref","DOI":"10.1177\/17448069211042117","article-title":"Tetrahydropalmatine exerts analgesic effects by promoting apoptosis and inhibiting the activation of glial cells in rats with inflammatory pain","volume":"17","author":"Liu","year":"2021","journal-title":"Mol. Pain"},{"issue":"11","key":"10.1016\/j.heliyon.2024.e33102_bib47","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1038\/s41401-020-00601-4","article-title":"Berberine alleviates visceral hypersensitivity in rats by altering gut microbiome and suppressing spinal microglial activation","volume":"42","author":"Zhang","year":"2021","journal-title":"Acta Pharmacol. Sin."},{"issue":"29","key":"10.1016\/j.heliyon.2024.e33102_bib48","doi-asserted-by":"crossref","first-page":"3956","DOI":"10.3748\/wjg.v25.i29.3956","article-title":"Berberine prevents stress-induced gut inflammation and visceral hypersensitivity and reduces intestinal motility in rats","volume":"25","author":"Yu","year":"2019","journal-title":"World J. Gastroenterol."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e33102_bib49","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1007\/s12026-017-8894-2","article-title":"Glycyrrhizin ameliorates experimental colitis through attenuating interleukin-17-producing T cell responses via regulating antigen-presenting cells","volume":"65","author":"Chen","year":"2017","journal-title":"Immunol. Res."},{"issue":"17","key":"10.1016\/j.heliyon.2024.e33102_bib50","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.3748\/wjg.v17.i17.2223","article-title":"Topical application of glycyrrhizin preparation ameliorates experimentally induced colitis in rats","volume":"17","author":"Kudo","year":"2011","journal-title":"World J. Gastroenterol."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e33102_bib51","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1111\/j.2042-7158.2010.01185.x","article-title":"Protective effects of glycyrrhizic acid by rectal treatment on a TNBS-induced rat colitis model","volume":"63","author":"Liu","year":"2011","journal-title":"J. Pharm. Pharmacol."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e33102_bib52","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1007\/s00535-010-0321-6","article-title":"Systematic review of animal models of post-infectious\/post-inflammatory irritable bowel syndrome","volume":"46","author":"Qin","year":"2011","journal-title":"J. Gastroenterol."},{"issue":"7","key":"10.1016\/j.heliyon.2024.e33102_bib53","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1111\/nmo.12358","article-title":"Cytokine imbalance in irritable bowel syndrome: a systematic review and meta-analysis","volume":"26","author":"Bashashati","year":"2014","journal-title":"Neuro Gastroenterol. Motil. : the Official Journal of the European Gastrointestinal Motility Society"},{"issue":"2","key":"10.1016\/j.heliyon.2024.e33102_bib54","first-page":"713","article-title":"Multi-layered prevention and treatment of chronic inflammation, organ fibrosis and cancer associated with canonical WNT\/\u03b2-catenin signaling activation","volume":"42","author":"Katoh","year":"2018","journal-title":"Int. J. Mol. Med."},{"issue":"11","key":"10.1016\/j.heliyon.2024.e33102_bib55","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1017\/S000711451400018X","article-title":"Effect of Triticum turgidum subsp. turanicum wheat on irritable bowel syndrome: a double-blinded randomised dietary intervention trial","volume":"111","author":"Sofi","year":"2014","journal-title":"Br. J. Nutr."},{"key":"10.1016\/j.heliyon.2024.e33102_bib56","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.cyto.2017.08.017","article-title":"Interleukin-6 in irritable bowel syndrome: a systematic review and meta-analysis of IL-6 (-G174C) and circulating IL-6 levels","volume":"99","author":"Bashashati","year":"2017","journal-title":"Cytokine"},{"issue":"2","key":"10.1016\/j.heliyon.2024.e33102_bib57","doi-asserted-by":"crossref","first-page":"G241","DOI":"10.1152\/ajpgi.00385.2010","article-title":"Colonic soluble mediators from the maternal separation model of irritable bowel syndrome activate submucosal neurons via an interleukin-6-dependent mechanism","volume":"300","author":"O'Malley","year":"2011","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e33102_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/j.mrrev.2009.01.001","article-title":"Translational regulation mechanisms of AP-1 proteins","volume":"682","author":"Vesely","year":"2009","journal-title":"Mutat. Res."},{"issue":"23","key":"10.1016\/j.heliyon.2024.e33102_bib59","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232314968","article-title":"Antidepressive effect of natural products and their derivatives targeting BDNF-TrkB in gut-brain Axis","volume":"23","author":"Liaqat","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e33102_bib60","doi-asserted-by":"crossref","first-page":"103","DOI":"10.3164\/jcbn.19-55","article-title":"Induction of brain-derived neurotrophic factor in enteric glial cells stimulated by interleukin-1\u03b2 via a c-Jun N-terminal kinase pathway","volume":"66","author":"Fukumoto","year":"2020","journal-title":"J. Clin. Biochem. Nutr."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e33102_bib61","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.coi.2009.12.004","article-title":"The inflammasomes: mechanisms of activation and function","volume":"22","author":"Latz","year":"2010","journal-title":"Curr. Opin. Immunol."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e33102_bib62","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.immuni.2008.02.005","article-title":"The NLR gene family: a standard nomenclature","volume":"28","author":"Ting","year":"2008","journal-title":"Immunity"},{"issue":"6","key":"10.1016\/j.heliyon.2024.e33102_bib63","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.coi.2007.09.002","article-title":"The inflammasome: a danger sensing complex triggering innate immunity","volume":"19","author":"P\u00e9trilli","year":"2007","journal-title":"Curr. Opin. Immunol."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e33102_bib64","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1007\/s00018-012-1070-x","article-title":"Regulation of intestinal epithelial permeability by tight junctions","volume":"70","author":"Suzuki","year":"2013","journal-title":"Cell. Mol. Life Sci. : CMLS"},{"issue":"8","key":"10.1016\/j.heliyon.2024.e33102_bib65","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1136\/gutjnl-2012-302093","article-title":"Diarrhoea-predominant irritable bowel syndrome: an organic disorder with structural abnormalities in the jejunal epithelial barrier","volume":"62","author":"Mart\u00ednez","year":"2013","journal-title":"Gut"},{"issue":"4","key":"10.1016\/j.heliyon.2024.e33102_bib66","doi-asserted-by":"crossref","first-page":"555","DOI":"10.3748\/wjg.v7.i4.555","article-title":"Relationship between plasma D(-)-lactate and intestinal damage after severe injuries in rats","volume":"7","author":"Sun","year":"2001","journal-title":"World J. Gastroenterol."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e33102_bib67","first-page":"289","article-title":"Heat stress-induced mucosal barrier dysfunction is potentially associated with gut microbiota dysbiosis in pigs","volume":"8","author":"Xia","year":"2022","journal-title":"Animal Nutrition (Zhongguo Xu Mu Shou Yi Xue Hui)"},{"issue":"6","key":"10.1016\/j.heliyon.2024.e33102_bib68","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1053\/j.gastro.2016.08.003","article-title":"Repeat treatment with rifaximin is safe and effective in patients with diarrhea-predominant irritable bowel syndrome","volume":"151","author":"Lembo","year":"2016","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.heliyon.2024.e33102_bib69","doi-asserted-by":"crossref","DOI":"10.1016\/j.chom.2018.03.004","article-title":"Listeria adhesion protein induces intestinal epithelial barrier dysfunction for bacterial translocation","volume":"23","author":"Drolia","year":"2018","journal-title":"Cell Host Microbe"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e33102_bib70","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s12974-023-02744-7","article-title":"Berberine ameliorates depression-like behaviors in mice via inhibiting NLRP3 inflammasome-mediated neuroinflammation and preventing neuroplasticity disruption","volume":"20","author":"Qin","year":"2023","journal-title":"J. Neuroinflammation"},{"issue":"2","key":"10.1016\/j.heliyon.2024.e33102_bib71","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.jinf.2017.12.013","article-title":"Gut dysbiosis and irritable bowel syndrome: the potential role of probiotics","volume":"76","author":"Principi","year":"2018","journal-title":"J. Infect."},{"issue":"5","key":"10.1016\/j.heliyon.2024.e33102_bib72","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1053\/j.gastro.2020.10.066","article-title":"The microbiota-gut-brain Axis: from motility to mood","volume":"160","author":"Margolis","year":"2021","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.heliyon.2024.e33102_bib73","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1136\/gutjnl-2019-319630","article-title":"Efficacy of faecal microbiota transplantation for patients with irritable bowel syndrome in a randomised, double-blind, placebo-controlled study","volume":"69","author":"El-Salhy","year":"2020","journal-title":"Gut"},{"key":"10.1016\/j.heliyon.2024.e33102_bib74","first-page":"80","article-title":"Effect of changji'an prescription on intestinal permeability of IBS-D \uff32ats","volume":"25","author":"Shi","year":"2019","journal-title":"Chin. J. Exp. Tradit. Med. Formulae"},{"issue":"7","key":"10.1016\/j.heliyon.2024.e33102_bib75","first-page":"905","article-title":"Effects of Changji\u2019an Formula on ultrastructure of colonic mucosa and levels of ZO- 1 and CLDN1 in model rats with IBS-D","volume":"32","author":"Zhu","year":"2021","journal-title":"Tradit. Chin. Drug Res. Clin. Pharmacol."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e33102_bib76","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/jcmm.14695","article-title":"Proteomics-based screening of the target proteins associated with antidepressant-like effect and mechanism of Saikosaponin A","volume":"24","author":"Guo","year":"2020","journal-title":"J. Cell Mol. Med."}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024091333?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024091333?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T20:59:49Z","timestamp":1790542789000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844024091333"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":76,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["S2405844024091333"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e33102","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Network pharmacology and experimental validation to explore the mechanism of Changji'an formula against irritable bowel syndrome with predominant diarrhea","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e33102","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e33102"}}